Key result
Unlicensed use of 3,4-methylenedioxymethamphetamine ('Ecstasy') during pregnancy was associated with acute myocardial infarction, highlighting a rare but serious risk of substance misuse.
Case Report (n=1)
Highlights the rare but serious risk of acute myocardial infarction associated with 'Ecstasy' misuse during pregnancy.
Answers are grounded in this paper and cite their sources.
Association of ecstasy with MI in pregnancy remains hypothesis-generating; does not support practice change without further evidence.
Acute myocardial infarction is rare in pregnancy; however, the emerging trend towards advanced maternal age and the rising prevalence of obesity and diabetes suggest that more cases of myocardial infarction are likely to be encountered in pregnancy. However, there is scanty evidence on the risk of myocardial infarction with regard to socially misused substances in pregnancy. We describe the management of a case of acute myocardial infarction following unlicensed use of 3,4-methylenedioxymethamphetamine ('Ecstasy') in pregnancy. The case highlights a rare but serious risk associated with substance misuse in pregnancy.
No takes yet. Share an insight, caveat, or question.
Okunoye et al. (2013) conducted a case report in Acute myocardial infarction in pregnancy (n=1). 3,4-methylenedioxymethamphetamine ('Ecstasy') was evaluated on Acute myocardial infarction. Unlicensed use of 3,4-methylenedioxymethamphetamine ('Ecstasy') during pregnancy was associated with acute myocardial infarction, highlighting a rare but serious risk of substance misuse.
Synapse has enriched 10 related papers. Consider them for comparative context: